Cellular Dynamics - Top 15 Biotech VC Deals of 2010

Company: Cellular Dynamics International
Based: Madison, WI
Amount: $40.6M

Investors: Tactics II Stem Cell Ventures, Sam Zell's Equity Group Investments and Sixth Floor Investors

Scoop: A 2008 Fierce 15 member, Cellular Dynamics added $40.6 million in Series B financing to grow its stem cell production. The company is the world's highest volume manufacturer of human heart cells and plans to use the added funds to enter other markets.

Cellular Dynamics - Top 15 Biotech VC Deals of 2010

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.